LIVE MARKET TRACKER :   BSE SENSEX   31679.05      |    NSE NIFTY 9876.50    
GLOBAL MARKETS :  NASDAQ 6426.922   +0.066%    |    FSI London 7310.64   +0.64%    |    NIKKEI Japan 20385.28   +0.44%
  USD GBP EUR CAD AUD INR
USD - 0.7392 0.8380 1.2330 1.2568 64.7525
GBP 1.3529 - 1.1336 1.6680 1.7001 87.6037
EUR 1.1936 0.8823 - 1.4717 1.5000 77.2886
CAD 0.8112 0.6000 0.6797 - 1.0197 52.5480
AUD 0.7959 0.5884 0.6669 0.9812 - 51.5110
INR 0.0154 0.0114 0.0129 0.0191 0.0194 -
Indian-Commodity  :  Equity & Shares  :  Glenmark Pharmaceuticals advances on receiving final approval by MHRA for Maloff Protect

Glenmark Pharmaceuticals advances on receiving final approval by MHRA for Maloff Protect (04-Jul-2017)

Glenmark Pharmaceuticals is currently trading at Rs. 642.55, up by 3.20 points or 0.50% from its previous closing of Rs. 639.35 on the BSE.

The scrip opened at Rs. 644.90 and has touched a high and low of Rs. 646.05 and Rs. 641.10 respectively. So far 9,657 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 993.00 on 01-Nov-2016 and a 52 week low of Rs. 600.00 on 29-May-2017.

Last one week high and low of the scrip stood at Rs. 646.05 and Rs. 625.00 respectively. The current market cap of the company is Rs. 18,130.00 crore.

The promoters holding in the company stood at 46.50%, while Institutions and Non-Institutions held 40.80% and 12.70% respectively.

Glenmark Pharmaceuticals Europe (Glenmark) has been granted final approval by the Medicines and Healthcare products Regulatory Agency (MHRA) for Maloff Protect (250mg/100mg atovaquone/proguanil film-coated tablets), anti-malarial medication, as a pharmacy license in the United Kingdom. Maloff Protect (250mg/100mg atovaquone/proguanil film-coated tablets) is the first OTC approval granted by the MHRA.

Maloff Protect will be used in the prevention of malaria in adults travelling to areas where malaria is prevalent. Maloff Protect contains atovaquone and proguanil hydrochloride, and has been available only as a prescription medicine in the UK. Under this approval, patients will be able to purchase Maloff Protect without a prescription.

Glenmark's current portfolio consists of +100 SKUs authorized for distribution in the UK, both in-licensed as well as Glenmark's own products. In addition to this approval Glenmark UK continues to identify and explore both internal as well as external development partnerships to supplement and accelerate the growth of its existing opportunities and future portfolio.



Top News Today
Zydus Cadila, Oberoi Realty and Artefact Projects to see some action today
(25-Sep-2017)

Zydus Cadila, Oberoi Realty and Artefact Projects to see some action todayZydus Cadila has received the final approval from the USFDA to market Amlodipine and Olmesartan Medoxomil Tablets in strengths of 5 mg/20 mg, 5 mg/40 mg 10 mg/20 mg, and 10 mg/40 mg. The drug is indicated......click on news to read complete article.

REC gets nod to raise Rs 65,000 crore via bonds
(23-Sep-2017)

REC gets nod to raise Rs 65,000 crore via bondsRural Electrification Corporation (REC) has received shareholders' approval to raise up to Rs 65,000 crore via bonds over the next one year. The special resolution was passed at the company's annual general......click on news to read complete article.

BNP Paribas Arbitrage sells 1.40 lakh shares of Matrimony.com
(23-Sep-2017)

BNP Paribas Arbitrage sells 1.40 lakh shares of Matrimony.comBNP Paribas Arbitrage has sold 1.40 lakh shares of Matrimony.com. The fund house has offloaded the same at Rs 817.73 on the NSE on September 22, 2017.Recently, BNP Paribas Arbitrage has offloaded 1,34,102......click on news to read complete article.

International Stock News
US markets end flat on geopolitical concerns
(23-Sep-2017)

US markets end flat on geopolitical concernsThe US markets ended the lackluster session near their neutral lines on Friday on geopolitical concerns amid an escalating war of words between North Korean leader Kim Jong Un and President Donald Trump.......click on news to read complete article.

Asian markets trade lower on heightened geopolitical tensions
(22-Sep-2017)

Asian markets trade lower on heightened geopolitical tensionsThe Asian markets are showing a weak trend on Friday, on renewed geopolitical worries after a report that North Korea could respond to fresh sanctions with a hydrogen bomb in the Pacific. A news report......click on news to read complete article.

US markets closed lower; Dow snaps nine-day winning streak
(22-Sep-2017)

US markets closed lower; Dow snaps nine-day winning streakThe US markets closed lower on Thursday, with the Dow snapping a nine-day winning streak as investors found few reasons to chase equities a day after the Federal Reserve indicated it still intends to deliver......click on news to read complete article.

 

     
  
Recent Equity & Shares News
 
EquityInvestmentCompany ReportsIPO
Disclaimer
By clicking on this page you accept all the terms and conditions framed by us. News made available here are for informational purpose only. While utmost care has been taken in providing the same. We claim no responsibility for its accuracy. Readers of this blog who make their decision based on the information posted here are solely responsible for their actions.